Hope on the horizon: FDA approves eplontersen for hereditary transthyretin-mediated amyloidosis

被引:0
|
作者
Anwar, Insa Binte [1 ]
Ahmed, Iqra Furqan [1 ]
Mahmood, Fariha [1 ]
Haseeb, Abdul [2 ]
Ahmed, Khabab Abbasher Hussien Mohamed [3 ]
机构
[1] Liaquat Natl Med Coll, Karachi, Pakistan
[2] Jinnah Sindh Med Univ, Karachi, Pakistan
[3] Univ Khartoum, Fac Med, Khartoum 11111, Sudan
来源
ANNALS OF MEDICINE AND SURGERY | 2025年 / 87卷 / 01期
关键词
D O I
10.1097/MS9.0000000000002839
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:20 / 23
页数:4
相关论文
共 50 条
  • [1] NEUROPATHY IMPAIRMENT AND NUTRITIONAL STATUS WITH EPLONTERSEN IN PATIENTS WITH HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS
    Conceicao, Isabel
    Wixner, Jonas
    Berk, John
    Adams, David
    Polydefkis, Michael
    Attarian, Shahram
    Gillmore, Julian
    Dyck, P. James
    Coelho, Teresa
    Chen, Jersey
    Hardy, Elise
    Kwoh, Jesse
    Natman, Jonatan
    Cruz, Marcia Waddington
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2024, 29 : S138 - S138
  • [2] A mini-review of Vutrisiran and Eplontersen in hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Olatunji, Gbolahan
    Kokori, Emmanuel
    Abraham, Israel Charles
    Omoworare, Oluwatobi
    Olatunji, Doyin
    Ezeano, Chimezirim
    Emmanuel Adeoba, Babawale
    Stanley, Anthony Chidera
    Oluwatobiloba, Awoyinfa Michael
    Oluwademilade, Omidiran Basit
    Shimelis, Kale Mekoya
    Olanisa, Olawale
    Aderinto, Nicholas
    MEDICINE, 2024, 103 (26) : e38767
  • [3] Neuropathy impairment and nutritional status with eplontersen in patients with hereditary transthyretin-mediated amyloidosis
    Wixner, Jonas
    Conceicao, Isabel
    Berk, John
    Adams, David
    Polydefkis, Michael
    Shahram, Attarian
    Gillmore, Julian D.
    Dyck, P. James B.
    Coelho, Teresa
    Chen, Jersey
    Hardy, Elise
    Kwoh, Jesse
    Natman, Jonatan
    Cruz, Marcia Waddington
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S68 - S68
  • [4] Patisiran in hereditary transthyretin-mediated amyloidosis
    Luigetti, Marco
    Servidei, Serenella
    LANCET NEUROLOGY, 2021, 20 (01): : 21 - 23
  • [5] Evaluation of methodologies for indirect comparison of eplontersen and vutrisiran for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Karam, Chafic
    Gillmore, Julian
    Chen, Gengshi
    Jenkins, Nia
    Hale, Mike
    Taylor, Gemma
    Chen, Jersey
    Viney, Nicholas
    Schneider, Eugene
    NEUROLOGY, 2023, 100 (17)
  • [6] FDA approves patisiran to treat hereditary transthyretin amyloidosis
    Wood H.
    Nature Reviews Neurology, 2018, 14 (10) : 570 - 570
  • [7] Patisiran for the treatment of hereditary transthyretin-mediated amyloidosis
    Yang, Junyi
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (02) : 95 - 99
  • [8] Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy
    Coelho, Teresa
    Marques, Wilson, Jr.
    Dasgupta, Noel R.
    Chao, Chi-Chao
    Parman, Yesim
    Franca, Marcondes Cavalcante, Jr.
    Guo, Yuh-Cherng
    Wixner, Jonas
    Ro, Long-Sun
    Calandra, Cristian R.
    Kowacs, Pedro A.
    Berk, John L.
    Obici, Laura
    Barroso, Fabio A.
    Weiler, Markus
    Conceicao, Isabel
    Jung, Shiangtung W.
    Buchele, Gustavo
    Brambatti, Michela
    Chen, Jersey
    Hughes, Steven G.
    Schneider, Eugene
    Viney, Nicholas J.
    Masri, Ahmad
    Gertz, Morie R.
    Ando, Yukio
    Gillmore, Julian D.
    Khella, Sami
    Dyck, P. James B.
    Cruz, Marcia Waddington
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (15): : 1448 - 1458
  • [9] Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis
    Nie, Tina
    Heo, Young-A
    Shirley, Matt
    DRUGS, 2023, 83 (15) : 1425 - 1432
  • [10] SIMULATED TREATMENT COMPARISON AND MATCHINGADJUSTED INDIRECT COMPARISON OF THE EFFICACY OF EPLONTERSEN AND VUTRISIRAN FOR THE TREATMENT OF HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS WITH POLYNEUROPATHY
    Karam, C.
    Gillmore, J. D.
    Chen, G.
    Jenkins, N. C.
    Hale, M. J.
    Chen, J.
    Viney, N. J.
    Schneider, E.
    VALUE IN HEALTH, 2023, 26 (12) : S46 - S47